Data / Drug companies / Aurore Pharmaceuticals Private Limited
Aurore Pharmaceuticals Private Limited: 34 products in the FDA NDC directory, labeler code 72761
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aurore Pharmaceuticals Private Limited (labeler code 72761) lists 34 products in the FDA National Drug Code Directory. By type: 34 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 28, 2026.
The request: Watch Aurore Pharmaceuticals Private Limited (FDA labeler code 72761): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72761
- Products in commercial distribution
- 34
- Packages
- 34
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 3
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- February 5, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 34 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 34 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 34 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Etoricoxib | 72761-043 | Powder | Bulk ingredients | October 28, 2026 |
| Sulindac | 72761-042 | Powder | Bulk ingredients | July 1, 2026 |
| Clozapine | 72761-041 | Powder | Bulk ingredients | May 1, 2026 |
| Indomethacin | 72761-040 | Powder | Bulk ingredients | December 1, 2025 |
| Cromolyn sodium | 72761-039 | Powder | Bulk ingredients | September 1, 2025 |
| Rilpivirine hydrochloride | 72761-038 | Powder | Bulk ingredients | November 25, 2024 |
| Tolvaptan | 72761-032 | Powder | Bulk ingredients | September 20, 2024 |
| Tofacitinib citrate | 72761-036 | Powder | Bulk ingredients | January 10, 2024 |
| Levothyroxine sodium | 72761-026 | Powder | Bulk ingredients | December 15, 2023 |
| Amlodipine besylate | 72761-034 | Powder | Bulk ingredients | July 22, 2022 |
| Oxcarbazepine | 72761-033 | Powder | Bulk ingredients | February 28, 2022 |
| Remdesivir | 72761-031 | Powder | Bulk ingredients | December 6, 2021 |
| Verapamil hydrochloride | 72761-030 | Powder | Bulk ingredients | July 7, 2021 |
| Valganciclovir hcl | 72761-029 | Powder | Bulk ingredients | May 8, 2021 |
| Nafamostat mesylate jp | 72761-028 | Powder | Bulk ingredients | July 25, 2020 |
| Salsalate | 72761-027 | Powder | Bulk ingredients | December 10, 2019 |
| Modafinil | 72761-023 | Powder | Bulk ingredients | August 5, 2019 |
| Valacyclovir hydrochloride | 72761-025 | Powder | Bulk ingredients | July 18, 2019 |
| Telmisartan | 72761-021 | Powder | Bulk ingredients | March 22, 2019 |
| Itraconazole | 72761-019 | Powder | Bulk ingredients | March 22, 2019 |
| Venlafaxine hydrochloride | 72761-018 | Powder | Bulk ingredients | March 22, 2019 |
| Tadalafil | 72761-017 | Powder | Bulk ingredients | March 22, 2019 |
| Mirtazapine anhydrous | 72761-015 | Powder | Bulk ingredients | March 22, 2019 |
| Eszopiclone | 72761-013 | Powder | Bulk ingredients | March 16, 2019 |
| Escitalopram oxalate | 72761-009 | Powder | Bulk ingredients | March 16, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.